The HYsteroscopic Miscarriage MaNagement Trial: A Pilot RCT Investigating a Novel Management Pathway for RPOC

NACompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

January 31, 2021

Primary Completion Date

November 2, 2022

Study Completion Date

November 2, 2022

Conditions
Retained Products After Miscarriage
Interventions
PROCEDURE

Outpatient hysteroscopy

Direct visualisation and careful extraction of retained pregnancy tissue using a specific hysteroscopic technology known as a hysteroscopic tissue retrieval system.

BEHAVIORAL

Expectant management

Leaving the retained pregnancy tissue alone to pass by itself

DRUG

Medical management

Giving medications to contract the womb to pass the retained pregnancy tissue

DRUG

Antibiotic

Giving antibiotics to reduce any inflammation/infection caused by the retained pregnancy tissue allowing it to pass by itself

PROCEDURE

Surgical management

Passing a small cannula/catheter/currette into the womb and mechanically scraping the womb lining to remove the retained pregnancy tissue

Trial Locations (1)

B15 2TG

Birmingham Women's Hospital, Birmingham

All Listed Sponsors
collaborator

Tommy's

OTHER

lead

Birmingham Women's and Children's NHS Foundation Trust

OTHER

NCT04751500 - The HYsteroscopic Miscarriage MaNagement Trial: A Pilot RCT Investigating a Novel Management Pathway for RPOC | Biotech Hunter | Biotech Hunter